Zeltiq Aesthetics Inc 4
4 · Zeltiq Aesthetics Inc · Filed Apr 28, 2017
Insider Transaction Report
Form 4
Endicott David J.
Director
Transactions
- Other
Common Stock
2017-04-28−16,132→ 0 total
Footnotes (2)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc., a wholly owned subsidiary of Allergan plc ("Allergan"), Blizzard Merger Sub, Inc. ("Merger Sub"), and the Issuer (the "Merger Agreement"), as approved by the board of directors of the Issuer, whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the "Merger").
- [F2]Pursuant to the terms of the Merger Agreement, out of the total of 16,132 shares held by the Reporting Person, (i) 8,477 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes, and (ii) 7,655 shares, representing unvested restricted stock units, were converted into a corresponding award of restricted stock units with respect to ordinary shares of Allergan, on the same terms and conditions as were applicable under such restricted stock units, as adjusted based on an exchange ratio.